Peanut allergy immunotherapy (DBV Technologies)
N/A
Report date: 2024/05/17 10:48:52
Base Information
Drug NamePeanut allergy immunotherapy (DBV Technologies)
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDbv Technologies
China Registration ClassN/A
Develop Information
Active CompaniesDbv Technologies
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A